1. Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., … CAPRISA 004 Trial Group. (2010). Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science, 329(5996), 1168–1174.
2. Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., & Puren, A. (2005). Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Medicine, 2(11), e298. https://doi.org/10.1371/journal.pmed.0020298
3. Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., & Krieger, J. N. … Ndinya-Achola, J. O. (2007). Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet, 369(9562), 643–656.
4. Beltrami, E. M., Luo, C.-C., de la Torre, N., & Cardo, D. M. (2002). Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen. Infection Control and Hospital Epidemiology, 23(6), 345–348.
5. Benn, P., Fisher, M., Kulasegaram, R., & BASHH, & PEPSE Guidelines Writing Group Clinical Effectiveness Group. (2011). UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011). International Journal of STD & AIDS, 22(12), 695–708.